Matthew Coffey - Net Worth and Insider Trading

Matthew Coffey Net Worth

The estimated net worth of Matthew Coffey is at least $74,281 dollars as of 2024-11-13. Matthew Coffey is the Director, Senior Officer of Oncolytics Biotech Inc and owns about 47,923 shares of Oncolytics Biotech Inc (TSX:ONC) stock worth over $74,281. Details can be seen in Matthew Coffey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Coffey has not made any transactions after 2019-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Matthew Coffey

To

Matthew Coffey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Coffey owns 1 companies in total, including Oncolytics Biotech Inc (TSX:ONC) .

Click here to see the complete history of Matthew Coffey’s form 4 insider trades.

Insider Ownership Summary of Matthew Coffey

Ticker Comapny Transaction Date Type of Owner
TSX:ONC Oncolytics Biotech Inc 2019-10-02 Director & Senior Officer

Matthew Coffey Latest Holdings Summary

Matthew Coffey currently owns a total of 1 stock. Matthew Coffey owns 47,923 shares of Oncolytics Biotech Inc (TSX:ONC) as of October 2, 2019, with a value of $74,281.

Latest Holdings of Matthew Coffey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:ONC Oncolytics Biotech Inc 2019-10-02 47,923 1.55 74,281

Holding Weightings of Matthew Coffey


Matthew Coffey Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Coffey has made a total of 0 transactions in Oncolytics Biotech Inc (TSX:ONC) over the past 5 years. The most-recent trade in Oncolytics Biotech Inc is the acquisition of 10,000 shares on October 2, 2019, which cost Matthew Coffey around $5,839.

Insider Trading History of Matthew Coffey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Coffey Trading Performance

GuruFocus tracks the stock performance after each of Matthew Coffey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Coffey is 395.35%. GuruFocus also compares Matthew Coffey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Coffey within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Matthew Coffey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Matthew Coffey

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 89.19 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 84.76 LIMIT LIMIT LIMIT LIMIT LIMIT

Matthew Coffey Ownership Network

Ownership Network List of Matthew Coffey

No Data

Ownership Network Relation of Matthew Coffey

Insider Network Chart

Matthew Coffey Owned Company Details

What does Oncolytics Biotech Inc do?

Who are the key executives at Oncolytics Biotech Inc?

Matthew Coffey is the Director & Senior Officer of Oncolytics Biotech Inc. Other key executives at Oncolytics Biotech Inc include and Senior Officer Kirk Look .

Oncolytics Biotech Inc (TSX:ONC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oncolytics Biotech Inc (TSX:ONC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncolytics Biotech Inc (TSX:ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oncolytics Biotech Inc (TSX:ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oncolytics Biotech Inc Insider Transactions

No Available Data

Matthew Coffey Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Coffey. Currently GuruFocus does not have mailing address information for Matthew Coffey.